AGREEMENT AND PLAN OF MERGER among Abbvie Inc., AThene subsidiary LLC, ATHENE MERGER SUB INC. and IMMUNOGEN, INC.. Dated as of November 30, 2023Agreement and Plan of Merger • November 30th, 2023 • ImmunoGen, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 30th, 2023 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER, dated as of November 30, 2023 (this “Agreement”), among AbbVie Inc., a Delaware corporation (“Parent”), Athene Subsidiary LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (“Intermediate Sub”), Athene Merger Sub Inc., a Massachusetts corporation and wholly owned Subsidiary of Intermediate Sub (“Purchaser”), and ImmunoGen, Inc., a Massachusetts corporation (the “Company”).